PCRX Form 144: 2,845-share option sale planned

Pacira BioSciences disclosed a Form 144 reporting a proposed sale of 2,845 shares via an option-related transaction to be effected on 04/21/2026 (option granted 11/04/2024) and a reported sale of 7,714 shares by Shawn Cross on 04/20/2026 for $193,912.22.

Rhea-AI Filing Summary

Pacira BioSciences disclosed a Form 144 reporting a proposed sale of 2,845 shares via an option-related transaction to be effected on 04/21/2026 (option granted 11/04/2024) and a reported sale of 7,714 shares by Shawn Cross on 04/20/2026 for $193,912.22.

Key Figures

Planned shares to be sold: 2,845 shares Shares sold: 7,714 shares Proceeds reported: $193,912.22 +1 more

4 metrics

Planned shares to be sold 2,845 shares Option-related transaction scheduled 04/21/2026 (option granted 11/04/2024)

Shares sold 7,714 shares Sale reported by Shawn Cross on 04/20/2026

Proceeds reported $193,912.22 Consideration for 7,714-share sale on 04/20/2026

Broker/dealer Fidelity Brokerage Services LLC Listed broker for the transactions (900 Salem Street, Smithfield RI)

Key Terms

Form 144, Option Granted, Cash

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Option Granted financial

"Securities To Be Sold | Option Granted - 11/04/2024"

Cash financial

"Securities To Be Sold | 04/21/2026 | Cash"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the PCRX Form 144 disclose about planned sales?

The filing discloses a planned sale of 2,845 shares tied to an option transaction scheduled for 04/21/2026. The entry notes the option was granted on 11/04/2024 and the method is listed as cash.

Who sold shares recently according to the PCRX Form 144?

Shawn Cross reported an open sale of 7,714 shares on 04/20/2026, with proceeds shown as $193,912.22. The filing lists the broker address for Fidelity Brokerage Services LLC.

Are the reported transactions linked to option exercises in the PCRX filing?

Yes. The planned 2,845-share transaction is labeled as an Option Granted event (grant date 11/04/2024) and is to be executed for cash on 04/21/2026 per the filing.

What broker/dealer handled the transactions in the PCRX Form 144?

The filing lists Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI 02917 as the broker/dealer associated with the reported securities activity on the Form 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/21/2026 - 04:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001734779
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pacira BioSciences, Inc.
SEC File Number	001-35060
Address of Issuer	2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CALIFORNIA 94005
Phone	650-242-8052
Name of Person for Whose Account the Securities are To Be Sold	Cross Shawn
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2845	71149.26	40489894	04/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/21/2026	Option Granted - 11/04/2024	Issuer			2845	04/21/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shawn Cross 2000 Sierra Point Parkway Suite 900 Brisbane CA 94005	Common	04/20/2026	7714	193912.22

144: Remarks and Signature

Remarks
Date of Notice	04/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Shawn Cross
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)